bioRxivMicrobiologyPreprint
Biphasic bactericidal activity of nitroxoline against Acinetobacter baumannii isolates from urinary tract infections
Xiaofei Yi, Xin CheniD, Minggui WangiD, Jianfeng ZhangiD, Xiaogang XuiD
Abstract
Acinetobacter baumannii is a critical pathogen which can cause hospital-acquired infections, particularly urinary tract infections (UTIs). The antimicrobial resistance (AMR) of A. baumannii is rising which poses a significant challenge to clinical management. Nitroxoline, an old antibiotic for treating uncomplicated UTIs, has gained renewed interest as a potential therapeutic option. Here, we investigates the bactericidal activity of nitroxoline against 34 A. baumannii (17 carbapenem-resistant and 17 carbapenem-sensitive isolates) collected from UTI patients. Nitroxoline exhibited a biphasic bactericidal effect, characterized by enhanced efficacy up to an optimal bactericidal concentration (OBC), followed by declined activity at higher nitroxoline concentrations. The OBCs, minimum bactericidal concentration (MBC), minimum inhibitory concentration (MIC), and time-killing curves were evaluated to elucidate bactericidal activity. Raman deuterium stable isotope probing (Raman-DIP) was employed to validate nitroxolines bactericidal effect and its impact on bacterial metabolic activity and survival rates. These results demonstrate that nitroxoline exhibits excellent inhibitory and bactericidal activity against A. baumannii. While nitroxoline exhibits biphasic bactericidal activity with OBC50/90 values of 4/8 mg/L. Raman spectroscopy identified a decreased C-D ratio as nitroxoline concentration increased, indicating reduced metabolic activity. Notably, an inverse correlation (r = -0.7594, p <0.0001) was observed between bacterial survival and the ccratio at concentrations above the OBC. These findings underscore the necessity of optimizing dosing regimens to enhance nitroxolines therapeutic efficacy and alleviate AMR development. Raman-DIP emerges as a robust tool for assessing nitroxolines effects on bacterial metabolism and determining MIC, offering valuable insights for future clinical applications.
- organism: human
- assay: metabolomics
- research focus: host-pathogen & immune response
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Uncovering nitroxoline activity spectrum, mode of action and resistance across Gram-negative bacteria
Elisabetta Cacace, Manuela Tietgen, … Stephan Göttig·Nature CommunicationsPeer-reviewed·Apr 22, 2025
- Monitoring the battlefield: Antimicrobial resistance, antibiofilm patterns and virulence factors of Acinetobacter baumannii isolates from hospital system
S. Awuor·bioRxiv·Dec 14, 2022
- Proguanil and chlorhexidine augment the antibacterial activities of clarithromycin and rifampicin against Acinetobacter baumannii
- Synergistic Interaction Between Nitrofurantoin and Dequalinium Provides a Promising Approach to Treating UTIs caused by Antibiotic-Resistant Klebsiella pneumoniae
Eric Cheuk-Kiu Cheung, Catherine Stevens, … Jessica C. S. Brown·bioRxiv·Aug 3, 2026
- Correlation analysis between drug resistance and virulence genes of carbapenem-resistant Acinetobacter baumannii In Western Guilin
- Antimicrobial activity of a repurposed harmine-derived compound on extensively drug-resistant Acinetobacter baumannii clinical isolates
A. Breine, M. Van Gysel, … C. Van der Henst·bioRxiv·Jun 30, 2021